Molecular mechanisms of activating c-MET in KSHV+ primary effusion lymphoma

The oncogenic Kaposi's sarcoma–associated herpesvirus (KSHV) is a principal causative agent of primary effusion lymphoma (PEL), which is mostly seen in immunosuppressed patients. PEL is a rapidly progressing malignancy with a median survival time of approximately 6 months even under the convent...

Descripción completa

Detalles Bibliográficos
Autores principales: Lam, Bao Quoc, Dai, Lu, Li, Li, Qiao, Jing, Lin, Zhen, Qin, Zhiqiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5392335/
https://www.ncbi.nlm.nih.gov/pubmed/28407694
http://dx.doi.org/10.18632/oncotarget.15444

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5392335/
https://www.ncbi.nlm.nih.gov/pubmed/28407694
http://dx.doi.org/10.18632/oncotarget.15444

Ejemplares similares